Amgen (AMGN) Restructuring Costs (2009 - 2026)

Amgen has reported Restructuring Costs for 16 years, with the latest figure at $116.0 million in Q2 2026.

• On a quarterly basis, Restructuring Costs rose 50.65% year-over-year to $116.0 million in Q2 2026; TTM through Jun 2026 was $408.0 million, a 60.73% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 429.03% from the prior year.
• Restructuring Costs was $116.0 million for Q2 2026 at Amgen, up from -$113.0 million in the prior quarter.
• The five-year high for Restructuring Costs was $830.0 million in Q1 2025, with the low at -$113.0 million in Q1 2026.
• Average Restructuring Costs over 3 years is $156.3 million, with a median of $76.5 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 690.48% in 2025, then tumbled 113.61% in 2026.
• Over 3 years, Restructuring Costs stood at $61.0 million in 2024, then advanced by 24.59% to $76.0 million in 2025, then jumped by 52.63% to $116.0 million in 2026.
• The last three Restructuring Costs figures came in at $116.0 million (Q2 2026), -$113.0 million (Q1 2026), and $76.0 million (Q4 2025), per Business Quant data.